VISTIN PHARMA ASA (VISTN.OL) Stock Income Statement
Europe - OSL:VISTN - NO0010734122 - Common Stock
23.2 NOK
+0.1 (+0.43%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 440.24M | 429.09M | 435.39M | 287.68M | 275.81M | |||
| Cost Of Goods | 146.62M | 149.97M | 176.64M | 138.06M | 96.10M | |||
| Gross Profit | 293.63M | 279.12M | 258.75M | 149.61M | 179.72M | |||
| Operating Expenses | 198.75M | 193.83M | 190.15M | 155.71M | 146.47M | |||
| Selling, General, and Administrative Expenses | 95.96M | 94.22M | 93.14M | 78.97M | 73.43M | |||
| Operating Income | 94.88M | 85.30M | 68.60M | -6.09M | 33.25M | |||
| Interest Income/Expense | 3.57M | -4.88M | -9.97M | 400.00K | -1.22M | |||
| Other Income/Expense | N/A | 37.00K | -112.00K | -313.00K | -35.00K | |||
| Income Before Taxes | 98.45M | 80.45M | 58.52M | -6.01M | 32.00M | |||
| Income Tax | 21.66M | 17.70M | 12.92M | -1.29M | 7.13M | |||
| Net Income | 76.79M | 62.75M | 45.60M | -4.72M | 24.87M | |||
| EBITDA | 114.10M | 104.33M | 85.94M | 6.18M | 43.86M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.73 | 1.42 | 1.03 | -0.11 | 0.56 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 66.70% | 65.05% | 59.43% | 52.01% | 65.16% | |||
| Profit Margin | 17.44% | 14.62% | 10.47% | -1.64% | 9.02% | |||
| Operating Profit Margin | 21.55% | 19.88% | 15.76% | -2.12% | 12.06% | |||
All data in NOK